Sep 17, 2024 · ... treatment of early-stage HR+/HER2- breast cancer in patients at high risk of recurrence. This ... Duration: 4:06 Posted: Sep 17, 2024
Sep 17, 2024 · Today, the FDA approved #ribociclib (Kisqali) in combination with an aromatase inhibitor for the ... Duration: 4:48 Posted: Sep 17, 2024